Identifying anti-TNF response biomarkers in ulcerative colitis using a diffusion-based signalling model
Permanent link
https://hdl.handle.net/10037/24185Date
2021-08-18Type
Journal articleTidsskriftartikkel
Peer reviewed
Abstract
Motivation: Resistance to anti-TNF therapy in subgroups of ulcerative colitis (UC) patients is a major challenge and incurs significant treatment costs. Identification of patients at risk of nonresponse to anti-TNF is of major clinical importance. To date, no quantitative computational framework exists to develop a complex biomarker for the prognosis of UC treatment. Modelling patient-wise receptor to transcription factor (TF) network connectivity may enable personalized treatment.
Results: We present an approach for quantitative diffusion analysis between receptors and TFs using gene expression data. Key TFs were identified using pandaR. Network connectivities between immune-specific receptor-TF pairs were quantified using network diffusion in UC patients and controls. The patient-specific network could be considered a complex biomarker that separates anti-TNF treatment-resistant and responder patients both in the gene expression dataset used for model development and separate independent test datasets. The model was further validated in rheumatoid arthritis where it successfully discriminated resistant and responder patients to tocilizumab treatment. Our model may contribute to prognostic biomarkers that may identify treatment-resistant and responder subpopulations of UC patients.
Availability and implementation: Software is available at https://github.com/Amy3100/receptor2tfDiffusion.
Supplementary information: Supplementary data are available at Bioinformatics Advances online.